文献速递肝病

酒精性与非酒精性脂肪性肝病与肝脏及心血管疾病相关住院风险

Alcoholic and Nonalcoholic Fatty Liver Disease and Incident Hospitalization for Liver and Cardiovascular Diseases.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-05-11

基于韩国218,030名健康体检者的队列研究,中位随访4.2年,比较非酒精性脂肪性肝病(NAFLD)与酒精相关性脂肪性肝病(AFLD)与肝脏及心血管疾病住院风险的关联。NAFLD患病率22.0%,AFLD患病率6.4%。AFLD与肝脏疾病住院风险升高相关(HR 5.00),NAFLD与心血管疾病住院风险升高相关(HR 1.20)。

要点

  • NAFLD患病率22.0%,AFLD患病率6.4%。
  • AFLD患者肝脏疾病住院风险显著升高(HR 5.00,95%CI 2.12-11.83)。
  • NAFLD患者心血管疾病住院风险轻度升高(HR 1.20,95%CI 1.02-1.40)。

核心结论

  • NAFLD或AFLD患者肝脏疾病相关住院风险升高,尤其在Fibrosis-4指数评分高者中。
  • NAFLD患者观察到心血管疾病相关住院风险升高,但AFLD患者中未观察到。

研究设计与样本

  • 来自Kangbuk Samsung健康研究的队列研究,纳入2011年至2016年在韩国接受健康检查的218,030名男性和女性。
  • 基线超声检测脂肪肝,Fibrosis-4指数评估肝纤维化,随访至多5.9年,收住院数据。

主要发现

  • NAFLD患病率22.0%,AFLD患病率6.4%。
  • 中位随访4.2年,观察到51例肝脏疾病相关住院和1097例心血管疾病相关住院。
  • 多变量调整后,与无过量饮酒且无脂肪肝的参照组相比,NAFLD和AFLD的肝脏疾病住院HR分别为1.73(95%CI 0.76-3.96)和5.00(95%CI 2.12-11.83)。
  • 心血管疾病住院HR分别为1.20(95%CI 1.02-1.40)和1.08(95%CI 0.86-1.34)。
  • 脂肪肝患者中,肝脏疾病住院风险随Fibrosis-4指数评分升高而增加,心血管疾病风险未增加。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: We compared the associations of nonalcoholic fatty liver disease (NAFLD) and alcohol-associated fatty liver disease (AFLD) with risk of incident hospitalization for liver and cardiovascular diseases. METHODS: We collected data from the Kangbuk Samsung Health Study on 218,030 men and women in Korea who underwent a health examination from 2011 through 2016. Fatty liver disease (FLD) was detected by ultrasound during the initial examination. The Fibrosis-4 index was used to identify individuals with liver fibrosis. Participants were followed up for as long as 5.9 years and data on hospitalizations for liver and cardiovascular diseases were collected. RESULTS: The prevalence of NAFLD was 22.0% and the prevalence of AFLD was 6.4%. Over a median follow-up period of 4.2 years, we observed 51 and 1097 incident cases of liver disease- or cardiovascular disease-related hospitalizations, respectively. After adjustment for potential confounders, the multivariable-adjusted hazard ratios for liver disease-related hospitalization, comparing NAFLD and AFLD with the reference category (no excessive alcohol intake and no FLD), were 1.73 (95% CI, 0.76-3.96) and 5.00 (95% CI, 2.12-11.83), respectively. The corresponding hazard ratios for cardiovascular disease hospitalization were 1.20 (95% CI, 1.02-1.40) and 1.08 (95% CI, 0.86-1.34), respectively. Among participants with FLD, the risk of liver disease-related hospitalization increased with high Fibrosis-4 index scores, whereas the risk of incident cardiovascular disease did not. CONCLUSIONS: In a large cohort study, we found an increased risk of liver disease-related hospitalizations for patients with NAFLD or AFLD, especially among those with Fibrosis-4 index scores. An increased risk of cardiovascular disease-associated hospitalization was observed in patients with NAFLD but not AFLD.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Chang Y, Cho J, Cho YK, et al. Alcoholic and Nonalcoholic Fatty Liver Disease and Incident Hospitalization for Liver and Cardiovascular Diseases. Clin Gastroenterol Hepatol. 2019. PMID: 31085337. doi:10.1016/j.cgh.2019.05.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。